Bejarano B, Manrique M
Departamento de Neurología y Neurocirugía, Clínica Universitaria de Navarra, Pamplona.
Neurocirugia (Astur). 2010 Feb;21(1):5-13.
Since its first description by Kux in 1954, the thoracic endoscopic (thoracoscopic) sympathectomy has rendered the open techniques obsolete in the treatment of the hyperhidrosis and other sympathetic-related diseases. AIM. The goal of this article is to present a critical review of the current indications, results and complications of the endoscopic thoracic sympathectomy.
An extensive search and review of published papers on the thoracoscopic sympathectomy was undertaken.
The thoracoscopic sympathectomy has evolved as a therapeutic choice in patients with focal hyperhidrosis, pain syndromes and peripheral vascular disorders, particularly. The results, recurrences and complications are similar to the previously established open procedures; nevertheless, the morbidity, the hospital stay and the time to return to activities of daily living are substantially reduced. The highest success and satisfaction rates (over 95%) were observed among patients treated for focal hyperhidrosis.
The success and complication rates of thoracoscopic sympathectomy are comparable to those of open techniques, with an easier postoperative period and an earlier return to labor and daily living.
自1954年库克斯首次描述以来，胸腔镜（胸交感神经）切除术已使开放性手术在治疗多汗症及其他交感神经相关疾病方面过时。目的。本文的目的是对目前胸腔镜交感神经切除术的适应证、结果及并发症进行批判性综述。
对已发表的关于胸腔镜交感神经切除术的论文进行广泛检索和综述。
胸腔镜交感神经切除术已发展成为治疗局限性多汗症、疼痛综合征和周围血管疾病患者的一种治疗选择。其结果、复发率和并发症与先前确立的开放性手术相似；然而，发病率、住院时间和恢复日常生活活动的时间大幅缩短。在接受局限性多汗症治疗的患者中观察到最高的成功率和满意度（超过95%）。
胸腔镜交感神经切除术的成功率和并发症发生率与开放性手术相当，术后恢复更容易，能更早恢复工作和日常生活。
